Css LLC Aldeyra Therapeutics, Inc. Transaction History

Css LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.8 - $7.74 $101,353 - $206,441	-26,672 Reduced 49.85%	26,828 $143,000
Q2 2022 Aug 15, 2022	BUY	$2.43 - $4.85 $102,060 - $203,699	42,000 Added 365.22%	53,500 $213,000
Q1 2022 May 16, 2022	SELL	$3.25 - $5.17 $11,375 - $18,095	-3,500 Reduced 23.33%	11,500 $51,000
Q4 2021 Feb 14, 2022	SELL	$3.5 - $9.63 $61,740 - $169,873	-17,640 Reduced 54.04%	15,000 $60,000
Q1 2021 May 17, 2021	BUY	$6.53 - $14.42 $213,139 - $470,668	32,640 New	32,640 $388,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $283M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.